Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYEndocrinology, diabetes & metabolism

Real-Time Continuous Glucose Monitoring Use and Kidney Function Among People With Diabetes and CKD or At-Risk for CKD.

  • Katia L Hannah1
  • Christina Chen1
  • Jessica R Castle2
  • Gregory J Norman1
  • Rodolfo J Galindo3
  1. 1Clinical Affairs, Dexcom, Inc., San Diego, California, USA.
  2. 2Medical Affairs, Dexcom, Inc., San Diego, California, USA.
  3. 3Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, Miami, Florida, USA.
Read full textPDFDOICite

Abstract

Introduction

Continuous glucose monitoring (CGM) use may benefit people with diabetes and chronic kidney disease (CKD). In this propensity-matched, retrospective analysis using Truveta-provided de-identified EMR data, changes in kidney function and glycemia were compared between cohorts starting real-time CGM (RT-CGM) use and CGM non-users (No CGM).Methods

Adults with type 1 or type 2 diabetes, treated with any insulin, with estimated glomerular filtration rate (eGFR) of 15-89 mL/min/1.73 m² were included. Changes in eGFR, albumin-to-creatinine ratio (ACR), and HbA1c between baseline and 3-year follow-up were assessed.Results

RT-CGM initiation (N = 518 per cohort) was associated with a significantly slower decline in eGFR compared to No CGM. There was no significant difference in change in ACR between the groups (N = 138 per cohort). RT-CGM use (N = 461 per cohort) was associated with a significantly greater decrease in HbA1c compared to No CGM.Conclusions

These findings support RT-CGM initiation among people with diabetes and CKD or at risk for CKD.

Related

  1. Person‐Reported and Continuous Glucose Monitoring ( CGM ) Recorded Hypoglycaemia in People With Insulin‐Treated Type 2 Diabetes and Mild to Moderate Chronic Kidney Disease; Post Hoc Analysis From the Hypo‐ METRICS Study
    Julie Brøsen, Daniel Malmsiø, Patrick Divilly +12
    Diabetes, Obesity and MetabolismPeer-reviewedCC BY-NC-ND 4.0Full textGeneral biologyEndocrinology & metabolismHAL
  2. Changes in CGM-Derived Glycemic Metrics and Triglyceride-Glucose Index During Ramadan in Adults With Type 2 Diabetes Using Real-Time Continuous Glucose Monitoring
    Ayman Al Hayek, Wael M. Al Zahrani, Mo’men Al Ajlouni +2
    Journal of Diabetes Science and TechnologyPeer-reviewedLicence not statedFull textPhysiologyPMC
  3. Performance and Safety of a Continuous Glucose Monitoring System in Pregnant Women With Gestational Diabetes Mellitus: A Multicenter, Open-Label Trial
    Jie Shen, Huiling Shang, Weiwei Zhu +1
    Journal of Diabetes Science and TechnologyPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  4. Real-world accuracy, extended-wear performance, and user satisfaction with a novel 21-day continuous glucose monitoring system in pediatric type 1 diabetes.
    Erdal Eren, Yasemin Denkboy Ongen, Burcu Eryilmaz +2
    BMJ open diabetes research & carePeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMC
  5. Distinct insulin sensitivity profiles revealed by clustering based on continuous glucose monitoring data in people living with type 1 diabetes
    Svjatoslavs Kistkins, Anastasija Luganceva, Sergejs Lobanovs +8
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC

Cite

BibTeXRIS
BibTeX
@article{hannah2026realtime,
  title = {{Real-Time Continuous Glucose Monitoring Use and Kidney Function Among People With Diabetes and CKD or At-Risk for CKD.}},
  author = {Katia L Hannah and Christina Chen and Jessica R Castle and Gregory J Norman and Rodolfo J Galindo},
  journal = {Endocrinology, diabetes \& metabolism},
  year = {2026},
  month = oct,
  doi = {10.1002/edm2.70344},
  url = {https://europepmc.org/article/MED/42912845},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Real-Time Continuous Glucose Monitoring Use and Kidney Function Among People With Diabetes and CKD or At-Risk for CKD.
AU  - Katia L Hannah
AU  - Christina Chen
AU  - Jessica R Castle
AU  - Gregory J Norman
AU  - Rodolfo J Galindo
PY  - 2026
DA  - 2026/10/30
JO  - Endocrinology, diabetes & metabolism
DO  - 10.1002/edm2.70344
UR  - https://europepmc.org/article/MED/42912845
AB  - Introduction  Continuous glucose monitoring (CGM) use may benefit people with diabetes and chronic kidney disease (CKD). In this propensity-matched, retrospective analysis using Truveta-provided de-identified EMR data, changes in kidney function and glycemia were compared between cohorts starting real-time CGM (RT-CGM) use and CGM non-users (No CGM).Methods  Adults with type 1 or type 2 diabetes, treated with any insulin, with estimated glomerular filtration rate (eGFR) of 15-89 mL/min/1.73 m² were included. Changes in eGFR, albumin-to-creatinine ratio (ACR), and HbA1c between baseline and 3-year follow-up were assessed.Results  RT-CGM initiation (N = 518 per cohort) was associated with a significantly slower decline in eGFR compared to No CGM. There was no significant difference in change in ACR between the groups (N = 138 per cohort). RT-CGM use (N = 461 per cohort) was associated with a significantly greater decrease in HbA1c compared to No CGM.Conclusions  These findings support RT-CGM initiation among people with diabetes and CKD or at risk for CKD.
SN  - 2398-9238
ER  -